Ancero, Liza Jane G.
HRN: 14-33-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2022
CEFUROXIME 500MG (TAB)
10/15/2022
10/22/2022
PO
500mg
BID
2nd Degree Laceration
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes